The National Institute of Allergy and Infectious Diseases announced it has started the first phase of a trial testing whether it is safe to mix COVID-19 vaccines from different manufacturers.
American pharmaceutical company Moderna says it has begun the process to win full U.S. regulatory approval for the use of its COVID-19 vaccine in adults.
Moderna said its COVID-19 vaccine strongly protects kids as young as 12; this could make it the 2nd option for that age group in the U.S.
We’re learning new information about Pfizer and Moderna’s vaccines, plus variants and boosters.
Moderna says its COVID-19 vaccine is 96% effective in kids ages 12-17. The company’s CEO said the shot was well tolerated in that age group, with no serious safety concerns.
Moderna is setting a goal to make up to one billion doses of its COVID-19 vaccine this year.
A new study suggests COVID-19 vaccines from Pfizer and Moderna do not appear to pose serious risk during pregnancy. Researchers reviewed data from more than 35,000 pregnant women from December of last year through February of this year.
The manufacturers of all three COVID-19 vaccines being used in the United States say they continue to conduct tests and are working to increase production capabilities.
Moderna is testing out its potential COVID-19 vaccine boosters for protection from emerging coronavirus variants. The vaccine maker announced that part of its phase two study has begun, and 60 participants who were already vaccinated with Moderna’s original COVID-19 vaccine will be given a booster of its modified vaccines.
Right now, the three COVID-19 vaccines on the U.S. market are for adults. You must be 18 or older to get Moderna and Johnson & Johnson vaccines, and 16 or older for the vaccine made by Pfizer. Clinical trials are now underway for younger children.
